TLC388
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TLC388, covering 2018-06-26 to 2019-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients [Phase 2]